Norges Bank Surmodics Inc Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.39 - $42.1 $802,324 - $1.33 Million	31,600 New	31,600 $1.33 Million
Q4 2023 Feb 09, 2024	BUY	$28.47 - $38.49 $899,652 - $1.22 Million	31,600 New	31,600 $1.15 Million
Q3 2023 Nov 13, 2023	SELL	$28.28 - $38.36 $559,944 - $759,528	-19,800 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$17.13 - $38.52 $1.08 Million - $2.43 Million	63,000 New	63,000 $1.44 Million
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $1.36 Million - $1.73 Million	46,300 New	46,300 $1.58 Million
Q3 2022 Nov 13, 2023	BUY	$28.84 - $38.92 $571,032 - $770,616	19,800 New	19,800 $601,000

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.